<img alt="" height="1" width="1" />Tioga Pharmaceuticals Begins Phase 3 Trial of Asimadoline in Irritable Bowel ...PR-USA.net (press release)Irritable bowel syndrome (IBS) is a common, chronic gastrointestinal disorder characterized by recurrent episodes of abdominal pain or discomfort associated ...<nobr></nobr> |